Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 3

1(16.7%)

6Total

N/A(5)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04939532Not ApplicableCompleted

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers

Role: collaborator

NCT04939519Not ApplicableCompleted

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers

Role: collaborator

NCT05533918Not ApplicableCompleted

SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Text Message Study

Role: collaborator

NCT05533359Not ApplicableCompleted

SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study

Role: collaborator

NCT04334382Phase 3Unknown

Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19

Role: collaborator

NCT01773759Not ApplicableCompleted

Immunization Protection in Child Care (IPiCC) Project

Role: collaborator

NCT00828490Completed

Electronic Pharmacotherapy Risk Management

Role: collaborator

All 7 trials loaded